Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Y Chu

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Journal of Cutaneous Pathology|February 6, 2026
PD-L1-Inhibitor-Associated Hidradenitis SuppurativaAnnie Jin, Katherine T Steele, Emily Y Chu
The American Journal of Dermatopathology|December 28, 2019
A Blue-Gray Macule on the Back: AnswerOyinade Aderibigbe, Caroline Groft-MacFarlane, Emily Y Chu
Journal of Cutaneous Pathology|May 15, 2015
Photo-distributed lichenoid eruption secondary to direct anti-viral therapy for hepatitis CCory L Simpson, Drew McCausland, Emily Y Chu
Human Pathology|May 5, 2023
Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findingsDylan Haynes, Eric E Morgan, Emily Y Chu
Cutis|September 4, 2014
Tender subcutaneous nodules on the back and shoulders. The diagnosis: prostate cancer metastasesSotonye Imadojemu, Phillip Holler, Emily Y Chu, et al.
The American Journal of Dermatopathology|March 12, 2014
Striking follicular eruption to pegylated liposomal doxorubicinJulia Dai, Robert Micheletti, Misha Rosenbach, et al.
JAMA Dermatology|April 16, 2020
Gene Expression Profile Testing for Thin Melanoma: Evidence to Support Clinical Use Remains ThinCarrie L Kovarik, Emily Y Chu, Adewole S Adamson
International Journal of Dermatology|May 30, 2012
Lymphedematous verrucous changes simulating squamous cell carcinoma in long-standing hidradenitis suppurativaEmily Y Chu, Carrie L Kovarik, Robert A Lee
Journal of Cutaneous Pathology|June 26, 2018
Pembrolizumab-induced sarcoidal infusion site reactionRobert J Smith, Tara C Mitchell, Emily Y Chu
Journal of Cutaneous Pathology|October 14, 2017
Lupus-like cutaneous reaction following pembrolizumab: An immune-related adverse event associated with anti-PD-1 therapyKimberly Shao, Suzanne McGettigan, Rosalie Elenitsas, et al.
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Journal of Cutaneous Pathology|February 6, 2026
PD-L1-Inhibitor-Associated Hidradenitis SuppurativaAnnie Jin, Katherine T Steele, Emily Y Chu
The American Journal of Dermatopathology|December 28, 2019
A Blue-Gray Macule on the Back: AnswerOyinade Aderibigbe, Caroline Groft-MacFarlane, Emily Y Chu
Journal of Cutaneous Pathology|May 15, 2015
Photo-distributed lichenoid eruption secondary to direct anti-viral therapy for hepatitis CCory L Simpson, Drew McCausland, Emily Y Chu
Human Pathology|May 5, 2023
Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findingsDylan Haynes, Eric E Morgan, Emily Y Chu
Cutis|September 4, 2014
Tender subcutaneous nodules on the back and shoulders. The diagnosis: prostate cancer metastasesSotonye Imadojemu, Phillip Holler, Emily Y Chu, et al.
The American Journal of Dermatopathology|March 12, 2014
Striking follicular eruption to pegylated liposomal doxorubicinJulia Dai, Robert Micheletti, Misha Rosenbach, et al.
JAMA Dermatology|April 16, 2020
Gene Expression Profile Testing for Thin Melanoma: Evidence to Support Clinical Use Remains ThinCarrie L Kovarik, Emily Y Chu, Adewole S Adamson
International Journal of Dermatology|May 30, 2012
Lymphedematous verrucous changes simulating squamous cell carcinoma in long-standing hidradenitis suppurativaEmily Y Chu, Carrie L Kovarik, Robert A Lee
Journal of Cutaneous Pathology|June 26, 2018
Pembrolizumab-induced sarcoidal infusion site reactionRobert J Smith, Tara C Mitchell, Emily Y Chu
Journal of Cutaneous Pathology|October 14, 2017
Lupus-like cutaneous reaction following pembrolizumab: An immune-related adverse event associated with anti-PD-1 therapyKimberly Shao, Suzanne McGettigan, Rosalie Elenitsas, et al.
Pageof 14